GUTS
Price
$0.42
Change
-$0.03 (-6.67%)
Updated
Feb 4, 02:48 PM (EDT)
Capitalization
68.94M
61 days until earnings call
Intraday BUY SELL Signals
QNCX
Price
$0.15
Change
-$0.00 (-0.00%)
Updated
Feb 4, 03:13 PM (EDT)
Capitalization
8.1M
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GUTS vs QNCX

Header iconGUTS vs QNCX Comparison
Open Charts GUTS vs QNCXBanner chart's image
Fractyl Health
Price$0.42
Change-$0.03 (-6.67%)
Volume$2.6K
Capitalization68.94M
Quince Therapeutics
Price$0.15
Change-$0.00 (-0.00%)
Volume$210
Capitalization8.1M
GUTS vs QNCX Comparison Chart in %
GUTS
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GUTS vs. QNCX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GUTS is a Hold and QNCX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (GUTS: $0.45 vs. QNCX: $0.15)
Brand notoriety: GUTS and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GUTS: 122% vs. QNCX: 320%
Market capitalization -- GUTS: $68.94M vs. QNCX: $8.1M
GUTS [@Biotechnology] is valued at $68.94M. QNCX’s [@Biotechnology] market capitalization is $8.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GUTS’s FA Score shows that 0 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • GUTS’s FA Score: 0 green, 5 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, QNCX is a better buy in the long-term than GUTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GUTS’s TA Score shows that 4 TA indicator(s) are bullish while QNCX’s TA Score has 4 bullish TA indicator(s).

  • GUTS’s TA Score: 4 bullish, 5 bearish.
  • QNCX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GUTS is a better buy in the short-term than QNCX.

Price Growth

GUTS (@Biotechnology) experienced а -78.90% price change this week, while QNCX (@Biotechnology) price change was -95.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

GUTS is expected to report earnings on Apr 06, 2026.

QNCX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GUTS($68.9M) has a higher market cap than QNCX($8.1M). GUTS YTD gains are higher at: -79.664 vs. QNCX (-95.660). QNCX has higher annual earnings (EBITDA): -44.18M vs. GUTS (-97.67M). GUTS has more cash in the bank: 77.7M vs. QNCX (26.3M). QNCX has less debt than GUTS: QNCX (18M) vs GUTS (62.2M). GUTS has higher revenues than QNCX: GUTS (3K) vs QNCX (0).
GUTSQNCXGUTS / QNCX
Capitalization68.9M8.1M851%
EBITDA-97.67M-44.18M221%
Gain YTD-79.664-95.66083%
P/E RatioN/AN/A-
Revenue3K0-
Total Cash77.7M26.3M295%
Total Debt62.2M18M346%
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
99
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GUTSQNCX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 23 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GUTS
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XMTR61.852.94
+4.99%
Xometry
FTI57.340.89
+1.58%
TechnipFMC plc
JXG4.200.03
+0.72%
JX Luxventure Group Inc.
ALT5.47-0.08
-1.44%
Altimmune
CDXS1.36-0.08
-5.56%
Codexis

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been closely correlated with QNCX. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if GUTS jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
-5.27%
QNCX - GUTS
70%
Closely correlated
-19.22%
RCKT - GUTS
33%
Loosely correlated
-0.57%
MNKD - GUTS
32%
Poorly correlated
+3.33%
NEVPF - GUTS
31%
Poorly correlated
N/A
UNCY - GUTS
31%
Poorly correlated
+7.29%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been closely correlated with GUTS. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if QNCX jumps, then GUTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-19.22%
GUTS - QNCX
70%
Closely correlated
-5.27%
MNPR - QNCX
33%
Poorly correlated
+2.15%
ADCT - QNCX
31%
Poorly correlated
N/A
CLNN - QNCX
29%
Poorly correlated
+5.69%
RAPT - QNCX
29%
Poorly correlated
+0.12%
More